Queen's Medical Center
Clinical trials sponsored by Queen's Medical Center, explained in plain language.
-
Can an arthritis drug tame severe COVID-19?
Disease control TerminatedThis study tested the drug tocilizumab (Actemra) in hospitalized adults with severe COVID-19 and signs of inflammation. Participants received either the drug or a placebo, with the goal of improving clinical status by day 28. The trial was terminated early after enrolling only 20…
Phase: PHASE3 • Sponsor: Queen's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Hydroxychloroquine COVID trial fizzles: only 17 patients enrolled
Disease control TerminatedThis study tested whether hydroxychloroquine (a malaria drug) could help hospitalized COVID-19 patients recover faster. It planned to enroll 350 people but was stopped early with just 17 participants. Because it ended so early, we cannot say whether the drug works or is safe for …
Phase: PHASE3 • Sponsor: Queen's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC